Nant Capital, LLC 13D and 13G filings for Panbela Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-24 8:02 pm Purchase | 2025-04-22 | 13D | Panbela Therapeutics, Inc. PBLA | Nant Capital, LLC | 32,432,432 86.980% | 30,005,366 (+1236.28%) | Filing |
| 2024-10-29 7:40 pm Purchase | 2024-10-22 | 13D | Panbela Therapeutics, Inc. PBLA | Nant Capital, LLC | 2,427,066 33.330% | 2,427,066 (New Position) | Filing |